Cannabix Marijuana Breath Test hardware including Breath Collection Unit (BCU) and Breath Cartridge (BC) technologies thumbnail from newly launched product video and corporate video. The launch of ...

Aegis Capital Corp. acted as exclusive placement agent for the offerings. Lucosky Brookman LLP acted as counsel to the Company. Kaufman & Canoles, P.C. acted as counsel to Aegis Capital Corp.

Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of ...

OncoInv has signed a distribution partnership with MaxBloch Clinical Laboratories to introduce the OncoSeek® multi-cancer early detection blood test in El Salvador, expanding access to affordable ...

The contributed shares are intended to support Mt. Bethel Fire Company initiatives that enhance safety, readiness, and emergency response capabilities. The donation was conducted in accordance with ...

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (“Salarius” or the “Company”) today announced that its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) scheduled for and convened on December ...

NDT Pharmaceuticals, Inc.’s (OTC: NDTP) wholly-owned subsidiary Good Salt Life, Inc., a pioneer in innovative surface treatment and biosecurity solutions, announces a groundbreaking achievement with ...

The NDA resubmission is supported by results from the successful Phase 3 PIVOT-PO trial (NCT number – NCT06059846). The trial was stopped early for efficacy in May, 2025 following a planned interim ...

By incorporating OpenAI-powered LLM tooling into its research and analytics stack, EMJX aims to strengthen multi-cycle strategy evaluation, dynamic volatility-management modeling, and decision support ...

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the latest addition to its industry-leading body of scientific and clinical evidence supporting the use of its dehydrated ...

Remedy's Nutrition® maintains the highest quality standards in producing this premium multivitamin formula. Unlike mass-produced supplements, each batch undergoes rigorous testing for purity, potency, ...

The collaboration explores the effect of Amplia’s FAK inhibitors in combination with experimental drugs called kRas inhibitors Melbourne, Australia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Amplia ...